DD
NVO

Dominick & Dominick’s Novo Nordisk NVO Stock Holding History

Dominick & Dominick’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-12,000
Closed -$203K – 202
2013
Q3 		$203K Sell
12,000
-45,500
-79% -$765K 0.11% 155
2013
Q2 		$891K Buy
+57,500
New +$957K 0.52% 63

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MAA
Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Dominick & Dominick's NVO Position: Q4 2013 in Review

Dominick & Dominick sold out of Novo Nordisk (NVO) in Q4 2013, closing a stake of 12,000 shares — an estimated $203K sold.

Dominick & Dominick first reported a position in NVO in Q2 2013 and held it in 2 quarters. The position peaked at $891K in Q2 2013. 431 funds tracked by Wall St. Rank hold NVO as of Q4 2013.

  • Dominick & Dominick reported no remaining Novo Nordisk position as of Q4 2013 after selling out during the quarter.
  • Dominick & Dominick sold 12,000 Novo Nordisk shares in Q4 2013, an estimated $203K.
  • Dominick & Dominick first reported a position in Novo Nordisk in Q2 2013 and held it in 2 quarters.
  • Dominick & Dominick's Novo Nordisk position peaked at $891K in Q2 2013.
  • 431 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2013.

Based on Dominick & Dominick's 13F filing for Q4 2013, filed 10 Feb 2014.